Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT02536404 · COMPLETED
Trial details
- NCT number
- NCT02536404
- Sponsor
- Arena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-25
- Primary completion
- 2018-11-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.